Mainz Biomed N.V. (QUCY)
NASDAQ: QUCY · Real-Time Price · USD
0.6917
-0.0457 (-6.20%)
At close: Mar 16, 2026, 4:00 PM EDT
0.7001
+0.0084 (1.21%)
After-hours: Mar 16, 2026, 6:00 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $8.66 million as of March 16, 2026. Its market cap has decreased by -57.46% in one year.
Market Cap
8.66M
Enterprise Value
9.34M
1-Year Change
-57.46%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since November 5, 2021, Mainz Biomed's market cap has decreased from $116.98M to $8.66M, a decrease of -92.60%. That is a compound annual growth rate of -45.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 9.23M | -9.05% |
| Dec 31, 2025 | 10.15M | -30.28% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 6.67% |
| Nov 5, 2021 | 116.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 880.03B |
| AstraZeneca | 589.05B |
| Johnson & Johnson | 582.04B |
| AbbVie | 388.43B |
| bioAffinity Technologies | 9.54M |
| Ernexa Therapeutics | 9.45M |
| SeaStar Medical Holding | 9.23M |
| Imunon | 9.18M |